FDA Investigator Dolores E Price

Dolores E Price has conducted inspections on 277 sites in 1 countries as of 19 Sep 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
277
Last Inspection Date:
19 Sep 2011
Investigator Role:
FDA Investigator
Redica ID:
100002006
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Dolores E Price:
Alan R Condon, Alexander M Kay, Alicia Aborg Borm, Alicia M Weitzel, Anita Narula, PhD, Arie C Menachem, Ashar P Parikh, Astrida B Mattson, Ava M Bowman, Avery J Dennis, Barbara D Wright, Barbara Janine Breithaupt, Barbara T Carmichael, Bradley Dworak, PhD, Bradley E Tufto, Brenda L Reihing, Brentley S Collins, Bryan Baker, Bryce E Mansfield, Burnell M Henry, Carl A Anderson, Caryn M Mcnab, Catherine J Laufmann, Ce'nedra M Martin, Christian D Lynch (CDL), Christina V Santos, Christine A Harman, PhD, Christopher S Genther, Cody D Rickman, Connie P Rezendes, Cynthia J Lee, MS, Dam S Barkans, Dan G Eisenbrey, Dana M Klimavicz, Dawn E Barkans, Deborah A Nebenzahl, Deborah Kleinfeld, Dennis G Kawabata, Dennis R Hudson, Devon M Shoop, Dianna D Wardlow Dotter, Dirk L Lincoln, Don A Brunssen, Don H Bark, PhD, Donald B Mckechnie, Donald W Jehn, Dr. Guang Gao, PhD, Edward A Brunt, Edward D Harris, Edwin Melendez, Eileen A Liu, Elizabeth D Connell, Elizabeth E Hart (ASCP), MT, Elmina E Akwo, Emily B Camire, Eric T Huebler, Francis A Guidry, Garrad R Poole, Gene D Arcy, Gerard Pde Leon, Gina C Collins, Gloria A Milster, Gloria J Baca, MS, Gordon T Wales, Hanna L Potter, Heika R Bounds, Heika R Tait, Hugh A Grimoldby, Jack L Christy, Jacqueline Mdiaz Albertini, James C Henry, James D Hildreth, Jane M Kreis, Jason T Lovelady, Jeffrey D Varelman, Jennifer L Bridgewater, Jessica B Clark, Jessica L Walters Moell, Jessica Walters Moell, Joey V Quitania, John A Iwen, John E Emmert, John W Banks, Julian C Hanson, Kaarin M Slotte, Karen J Bak, Kari M Johansen, Kathryn A Krentz, Kellie L Westerbuhr, Kelly D Moore, Kenneth O Gee, PhD, Kip J Hanks, Kristin M Abaonza, Laura Kathryn, Laurel A Beer, Lauren E Swantko, Laverne Puckett, LCDR Debra Emerson, LCDR Ismael Olvera, IV, Lee Terry Moore, Lesley A Swanson, Leya A Grosch, Linda S Leja, Lisa K Capron, Lisa M Althar, Lori J Silverstein, LTJG Bradley E Benasutti, Lynda L Perry, PhD, Marc A Jackson, Jr, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mariza M Jafary, Mark E Moen, Mark W Babbitt, Marlene L Davis, Maxine H Wong, Michael F Schuette, Mihaly S Ligmond, Mikel T Wright, Nancy A Saxenian Emmons, Omotunde O Osunsanmi, Othello G Capangpangan, Ounchith J Phabmixay, Paul M Chefor, Paul M Kawamoto, Paula A Trost, Peter Kessler, PhD, Philip E Ake, Prabhu P Raju, Randy L Self, Rebecca Rodriguez, Rebecca T Davis, Richard Heath Coats, Richard J Bashay, Richard L Bartlett, Richard T Riggie, Robert D Tollefsen, Rocco C Black, Roger D Gawne, Roger J Adams, S Lori Brown, PhD MPH, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Scott A Nabe, Scott Reynolds, Scott W Fox, Sharon I Gundersen, Shelley H Beausoleil, Stephen D Weagant, Stephen R Souza, Stuart W Russell, Sunitha K Rajaram, PhD, Sunny R Muir, Susan F Laska, MS, Terri L Dodds, Thomas J Arista, Tiana M Mckinley, Tina S Roecklein, Tracy K Li, Travis S Bradley, Uttaniti Limchumroon (Tom), Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Victoria V Bot, William D Bassett, Jr, Xiaojun Yan, Xiomara Copeland, Young M Yoon

Dolores E Price's Documents

Publish Date Document Type Title
January, 2002 FDA 483 Response Adventist Health Walla Walla General Hospital - Form 483R, 2002-02-04
August, 2003 FDA 483 Response Bloodworks Northwest - Form 483R, 2003-08-21
August, 2002 EIR US Foods Inc - EIR, 2002-08-01
August, 2000 EIR Jubilant HollisterStier LLC - EIR, 2000-08-09
August, 2003 FDA 483 Bloodworks Northwest - Form 483, 2003-08-01
July, 2002 FDA 483 Biomat USA Inc - Form 483, 2002-07-03
August, 2000 EIR University of Washington CHRMC Virology Laboratory - EIR, 2000-08-23
April, 2004 FDA 483 Our Lady of the Lake Hospital, Inc. - Form 483, 2004-04-08
January, 2002 FDA 483 Adventist Health Walla Walla General Hospital - Form 483, 2002-01-16
January, 2002 FDA 483 SeraCare, Inc. - Form 483, 2002-01-23
July, 2002 EIR Biomat USA Inc - EIR, 2002-07-03
December, 2000 FDA 483 Amram Inc. - Form 483, 2000-12-18
September, 2003 EIR Bloodworks - EIR, 2003-09-12
January, 2002 EIR Adventist Health Walla Walla General Hospital - EIR, 2002-01-16
September, 2003 FDA 483 Bloodworks - Form 483, 2003-09-12
September, 2003 FDA 483 Response Bloodworks - Form 483R, 2003-09-30
February, 2000 EIR Jubilant HollisterStier LLC - EIR, 2000-02-03
August, 2001 FDA 483 Bio-Rad Laboratories, Inc. - Form 483, 2001-08-22
April, 2004 EIR Our Lady of the Lake Hospital, Inc. - EIR, 2004-04-08
April, 2004 FDA 483 Response Our Lady of the Lake Hospital, Inc. - Form 483R, 2004-04-21
August, 2000 FDA 483 University of Washington CHRMC Virology Laboratory - Form 483, 2000-08-23
August, 2001 FDA 483 University of Washington CHRMC Virology Laboratory - Form 483, 2001-08-24
June, 2009 FDA 483 Takeda Pharmaceutical Company Limited - Form 483, 2009-06-11
August, 2002 FDA 483 Spokane Produce, Inc. - Form 483, 2002-08-09
August, 2002 EIR Spokane Produce, Inc. - EIR, 2002-08-16
August, 2003 EIR Bloodworks Northwest - EIR, 2003-08-01
August, 2001 EIR University of Washington CHRMC Virology Laboratory - EIR, 2001-08-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more